Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
Contributors
Finckh, AxelPublished in
Joint bone spine, vol. 77, no. 4, p. 313-318Publication date
2010Abstract
Keywords
- Aged
- Aged, 80 and over
- Antibodies, Anti-Idiotypic/blood
- Antibodies, Monoclonal/blood/therapeutic use
- Arthritis, Rheumatoid/drug therapy
- Biological Markers/blood
- Case-Control Studies
- Cohort Studies
- Dose-Response Relationship, Drug
- Drug Resistance
- Female
- Humans
- Logistic Models
- Male
- Middle Aged
- Time Factors
- Treatment Outcome
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
FINCKH, Axel et al. Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients. In: Joint bone spine, 2010, vol. 77, n° 4, p. 313–318. doi: 10.1016/j.jbspin.2010.02.021
Main files (1)
Article (Published version)
Identifiers
- PID : unige:20934
- DOI : 10.1016/j.jbspin.2010.02.021
- PMID : 20471890
